RELINIFY
Live / Applied — New application — not yet assigned to an examiner (as of 17 Sept 2026)
What this means for you
Not registered yet, but its 17 Sept 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 50114329
- Mark type
- Stylized text
- Filed
- 17 Sept 2026
- Attorney of record
- Karl M. Zielaznicki
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders.
Owner
- Takeda Pharmaceuticals U.S.A., Inc., Cambridge, MA, US
Prosecution history
- 17 Sept 2026 — APPLICATION FILING RECEIPT MAILED
- 17 Sept 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Sept 2026 — NEW APPLICATION ENTERED